Defence Therapeutics Inc.

Defence Therapeutics Inc. - ROEverified

DTCFF

Price:

$0.3387

Market Cap:

$30.98M

Defence Therapeutics Inc., a biotechnology firm, is committed to the research and development of innovative biological and biosimilar therapeutic agents for both cancer and infectious diseases. Central to its strategy is the proprietary ACCUM™ technology platform, which ensures the precise and intact delivery of vaccine antigens or antibody-drug conjugates (ADCs) to their intended target cells. The company's development pipeline primarily concentrates on three key areas: dendritic cell-based cancer vaccines, protein-based vaccine formulations for COVID-19 and other infectious illnesses, and various antibody-drug conjugate (ADC) products designed to address different cancers. Founded in 2017,...[Read more]

Industry

Biotechnology

IPO Date

2021-05-18

Stock Exchange

OTC

Ticker

DTCFF

The ROE as of June 2026 (TTM) for Defence Therapeutics Inc. (DTCFF) is -1661.38%

According to Defence Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -1661.38%. This represents a change of -3237.68% compared to the average of 52.95% of the last 4 quarters.

Defence Therapeutics Inc. (DTCFF) Historical ROE (quarterly & annually)

How has DTCFF ROE performed in the past?

The mean historical ROE of Defence Therapeutics Inc. over the last ten years is 664.74%. The current -1661.38% ROE has changed -349.93% with respect to the historical average. Over the past ten years (40 quarters), DTCFF's ROE was at its highest in in the September 2019 quarter at 8.83%. The ROE was at its lowest in in the March 2022 quarter at -111.91%.

Quarterly (TTM)
Annual

Average

664.74%

Median

280.46%

Minimum

-431.80%

Maximum

2.63%

Defence Therapeutics Inc. (DTCFF) ROE by Quarter and Year

Discovering the peaks and valleys of Defence Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 44.26%

Maximum Annual ROE = 2.63%

Minimum Annual Increase = -3736.44%

Minimum Annual ROE = -431.80%

Quarterly (TTM)
Annual
YearROEChange
2025280.46%-23.81%
2024368.09%-185.24%
2023-431.80%-122.79%
20221.89%-3736.44%
2021-52.11%44.26%
2020-36.12%-101.37%

Defence Therapeutics Inc. (DTCFF) Average ROE

How has DTCFF ROE performed in the past?

The current ROE of Defence Therapeutics Inc. (DTCFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

72.25%

5-year avg

411.91%

10-year avg

664.74%

Defence Therapeutics Inc. (DTCFF) ROE vs. Peers

How is DTCFF’s ROE compared to its peers?

Defence Therapeutics Inc.’s ROE is less than Provectus Biopharmaceuticals, Inc. (89.65%), less than Sernova Corp. (55.85%), less than MedMira Inc. (15.28%), greater than Cynata Therapeutics Limited (-179.37%), greater than Microbix Biosystems Inc. (-21.02%), less than Starpharma Holdings Limited (-15.96%), greater than Celyad Oncology S.A. (-242.11%), greater than Bonus BioGroup Ltd. (-1541.00%), less than WOWI, Inc. (157.95%), greater than Finch Therapeutics Group, Inc. (-86.83%),

Build a custom stock screener for Defence Therapeutics Inc. (DTCFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Defence Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Defence Therapeutics Inc. (DTCFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Defence Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Defence Therapeutics Inc.'s ROE?

How is the ROE calculated for Defence Therapeutics Inc. (DTCFF)?

What is the highest ROE for Defence Therapeutics Inc. (DTCFF)?

What is the 3-year average ROE for Defence Therapeutics Inc. (DTCFF)?

What is the 5-year average ROE for Defence Therapeutics Inc. (DTCFF)?

How does the current ROE for Defence Therapeutics Inc. (DTCFF) compare to its historical average?